BioNote

바이오노트KRX: 377740· Fiscal year 2025· bionote.co.kr ↗

Average salary
$40.4K
₩53.8M
▼ 2.7% vs 2024
Employees
334
▲ 6.7% vs 2024
Average tenure
4.8 yrs

Estimated take-home of this pay:$2.8K / monthCalculate →

Workplace

Women's pay (men = 100)65
Women among staff61.1%
Contract staff7.2%

Recent official filings

Quick read

  • Average pay is 12% below the median of the companies we track.
  • Average pay fell 2.7% from 2024.
  • Headcount grew by 21 (6.7%) from 2024.
  • Ranks #148 of 238 Healthcare & Pharma companies in this country by pay.
  • Revenue grew 15.1% year over year.
  • Revenue has grown two years in a row.
  • Operating margin was 14.1% in 2025.
  • Operating loss of $35.2M in 2023.

Last 3 years

Revenue
$67.6M2023$77.1M2024$88.8M2025
Operating income
-$35.3M2023$9.2M2024$12.5M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$265.3K
Net profit per employee
-$196.2K
Operating margin
14.1%
Net margin
-73.9%
ROE
-5.8%
Debt-to-equity
3.0%
Equity ratio
97.1%
Dividend per share
$0
Dividend yield (as disclosed)
3.8%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.